Tissue-specific bioconcentration of antidepressants in fish exposed to effluent from a municipal sewage treatment plant

Science of the Total Environment

Volumn 488-489, Issue 1, 2014, Pages 46-50

  Grabicova, Katerina ^a   Lindberg, Richard H ^b   Östman, Marcus ^b   Grabic, Roman ^a   Randak, Tomas ^a   Joakim Larsson, D G ^c   Fick, Jerker ^b  

^a UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Brain; Caged fish; Liver; Rainbow trout; Selective serotonin reuptake inhibitors; Venlafaxine

Indexed keywords

BIOACCUMULATION; BLOOD; BRAIN; DRUG PRODUCTS; EFFLUENT TREATMENT; EFFLUENTS; FISH; HISTOLOGY; LIVER; MAMMALS; SEWAGE TREATMENT PLANTS; TISSUE;

CAGED FISH; EXPOSURE CONCENTRATION; LIMIT OF QUANTIFICATIONS; MUNICIPAL SEWAGE TREATMENT PLANT; RAINBOW TROUT; RAINBOW TROUTS (ONCORHYNCHUS MYKISS); SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS; VENLAFAXINE;

TISSUE ENGINEERING;

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; SERTRALINE; VENLAFAXINE;

BIOACCUMULATION; BIOLOGICAL UPTAKE; BLOOD; BRAIN; CONCENTRATION (COMPOSITION); EFFLUENT; PHYSIOLOGICAL RESPONSE; SAFETY; SALMONID; SEWAGE TREATMENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSAFETY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; ENVIRONMENTAL EXPOSURE; LIMIT OF QUANTITATION; NONHUMAN; PRIORITY JOURNAL; RAINBOW TROUT; SEWAGE EFFLUENT; SEWAGE TREATMENT PLANT; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; WATER POLLUTANT;

SWEDEN;

BRAIN; CAGED FISH; LIVER; RAINBOW TROUT; SELECTIVE SEROTONIN REUPTAKE INHIBITORS; VENLAFAXINE;

ANIMALS; ANTIDEPRESSIVE AGENTS; ENVIRONMENTAL MONITORING; ONCORHYNCHUS MYKISS; SEWAGE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

EID: 84899832337     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.04.052     Document Type: Article

References (44)

1. Aryal B., Aryal D., Kim E.J., Kim H.G. Pharmacokinetics of venlafaxine and its major metabolite o-desmethylvenlafaxine in freely moving mice using automated dosing/sampling system. Indian J Pharmacol 2012, 44:20-25.
2. Brodin T., Fick J., Jonsson M., Klaminder J. Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 2013, 339:814-815.
3. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., et al. Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 2005, 24:464-469.
4. Christen V., Hickmann S., Rechenberg B., Fent K. Highly active human pharmaceuticals in aquatic systems: a concept for their identification based on their active mode of action. Aquat Toxicol 2010, 96:167-181.
5. Corcoran J., Winter M.J., Tyler C.R. Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish. Crit Rev Toxicol 2010, 40:287-304.
6. De Lange H.J., Noordoven W., Murk A.J., Lurling M., Peeters E.T.H.M. Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. Aquat Toxicol 2006, 78:209-216.
7. DeVane C.L. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 1999, 19:443-466.
8. Du B., Perez-Hurtado P., Brooks B.W., Chambliss C.K. Evaluation of an isotope dilution liquid chromatography tandem mass spectrometry method for pharmaceuticals in fish. J Chromatogr A 2012, 1253:177-183.
9. Du B., Price A.E., Scott W.C., Kristofco L.A., Ramirez A.J., Chambliss C.K., et al. Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent. Sci Total Environ 2014, 466-467:976-984.
10. Fedorova G., Nebesky V., Randak T., Grabic R. Simultaneous determination of 32 antibiotics in aquaculture products using LC-MS/MS. Chem Pap 2014, 68:29-36.
11. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76:122-159.
12. Fick J., Lindberg R.H., Tysklind M., Larsson D.G.J. Predicted critical environmental concentrations for 500 pharmaceuticals. Regul Toxicol Pharmacol 2010, 58:516-523.
13. Gelsleichter J., Szabo N.J. Uptake of human pharmaceuticals in bull sharks (Carcharhinus leucas) inhabiting a wastewater-impacted river. Sci Total Environ 2013, 456:196-201.
14. Grabic R., Fick J., Lindberg R.H., Fedorova G., Tysklind M. Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry. Talanta 2012, 100:183-195.
15. Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O., Larsson D.G.J. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 2008, 42:5807-5813.
16. Halling-Sorensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lutzheft H.C., Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 1998, 36:357-393.
17. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 2002, 131:5-17.
18. Henry T.B., Kwon J.W., Armbrust K.L., Black M.C. Acute and chronic toxicity of five selective serotonine reuptake inhibitors in Ceriodaphnia dubia. Environ Toxicol Chem 2004, 23:2229-2233.
19. Hiemke C., Hartter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 2000, 85:11-28.
20. Holmberg A., Fogel J., Albertsson E., Fick J., Brown J.N., Paxeus N., et al. Does waterborne citalopram affect the aggressive and sexual behaviour of rainbow trout and guppy?. J Hazard Mater 2011, 187:596-599.
21. Huerta B., Rodriguez-Mozaz S., Barcelo D. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications. Anal Bioanal Chem 2012, 404:2611-2624.
22. Huggett D.B., Cook J.C., Ericson J.F., Williams R.T. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum Ecol Risk Assess 2003, 9:1789-1799.
23. Hughes S.R., Kay P., Brown L.E. Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environ Sci Technol 2013, 47:661-677.
24. Kidd K.A., Blanchfield P.J., Mills K.H., Palace V.P., Evans R.E., Lazorchak J.M., et al. Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci U S A 2007, 104:8897-8901.
25. Kullgren A., Samuelsson L., Larsson D.G.J., Björnsson Th., Jönsson Bergman E. A metabolomics approach to elucidate effects of food deprivation in juvenile rainbow trout (Oncorhynchus mykiss). Am J Physiol Regul Integr Comp Physiol 2010, 299:R1440-R1448.
26. Kullgren A., Jutfelt F., Fontanillas R., Sundell K., Samuelsson L.M., Wiklander K., et al. The impact of temperature on the metabolome and endocrine metabolic signaling in Atlantic salmon (Salmo salar). Comp Biochem Physiol A Mol Integr Physiol 2013, 164:44-53.
27. Lajeunesse A., Gagnon C., Gagne F., Louis S., Cejka P., Sauve S. Distribution of antidepressants and their metabolites in brook trout exposed to municipal wastewaters before and after ozone treatment-evidence of biological effects. Chemosphere 2011, 83:564-571.
28. Lewis R.J., Angier M.K., Williamson K.S., Johnson R.D. Analysis of sertraline in postmortem fluids and tissues in 11 aviation accident victims. J Anal Toxicol 2013, 37:208-216.
29. Metcalfe C.D., Chu S., Judt C., Li H., Oakes K.D., Servos M.R., et al. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ Toxicol Chem 2010, 29:79-89.
30. Petrovic M., Gonzalez S., Barcelo D. Analysis and removal of emerging contaminants in wastewater and drinking water. Trac Trends Anal Chem 2003, 22:685-696.
31. Ramirez A.J., Mottaleb M.A., Brooks B.W., Chambliss C.K. Analysis of pharmaceuticals in fish using liquid chromatography-tandem mass spectrometry. Anal Chem 2007, 79:3155-3163.
32. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., et al. Occurrence of pharmaceuticals and personal care products in fish: results of a national pilot study in the United States. Environ Toxicol Chem 2009, 28:2587-2597.
33. Rand-Weaver M., Margiotta-Casaluci L., Patel A., Panter G.H., Owen S.F., Sumpter J.P. The read-across hypothesis and environmental risk assessment of pharmaceuticals. Environ Sci Technol 2013, 47:11384-11395.
34. Santos L., Araujo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 2010, 175:45-95.
35. Schultz M., Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 2003, 58:447-474.
36. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., et al. Antidepressant pharmaceuticals in two US effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ Sci Technol 2010, 44:1918-1925.
37. Schultzt M.M., Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal Chem 2008, 80:1756-1762.
38. Unceta N., Ugarte A., Sanchez A., Gomez-Caballero A., Aranzazu Goicolea M., Barrio R.J. Development of a stir bar sorptive extraction based HPLC-FLD method for the quantification of serotonin reuptake inhibitors in plasma, urine and brain tissue samples. J Pharm Biomed Anal 2010, 51:178-185.
39. Valenti T.W., Gould G.G., Berninger J.P., Connors K.A., Keele N.B., Prosser K.N., et al. Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows. Environ Sci Technol 2012, 46:2427-2435.
40. Vasskog T., Berger U., Samuelsen P.J., Kallenborn R., Jensen E. Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso, Norway. J Chromatogr A 2006, 1115:187-195.
41. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci Total Environ 2012, 429:123-155.
42. Wang J., Gardinali P.R. Analysis of selected pharmaceuticals in fish and the fresh water bodies directly affected by reclaimed water using liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2012, 404:2711-2720.
43. Wikell C., Hjorth S., Apelqvist G., Kullimgsjo J., Lundmark J., Bergqvist P.B.F., et al. Suistained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings. Naunyn Schmiedebergs Arch Pharmacol 2001, 363:448-455.
44. Wille S.M.R., De Letter E.A., Piette M.H.A., Van Overschelde L.K., Van Peteghem C.H., Lambert W.E. Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography-mass spectrometry. Int J Legal Med 2009, 123:451-458.